This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Dicerna Pharmaceuticals, Inc.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Boyoung Kim: Innovator in LDHA Expression Inhibition
Introduction
Boyoung Kim is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of inhibiting the expression of LDHA. With a total of 2 patents to his name, his work has the potential to impact various therapeutic applications.
Latest Patents
Boyoung Kim's latest patents focus on methods and compositions for inhibiting the expression of LDHA. This disclosure relates to oligonucleotides, compositions, and methods that are useful for reducing LDHA expression, particularly in hepatocytes. His innovative approaches aim to provide new avenues for treatment in related medical conditions.
Career Highlights
Throughout his career, Boyoung Kim has worked with prominent companies in the biotechnology sector. He has been associated with Dicerna Pharmaceuticals, Inc. and Novo Nordisk Healthcare AG. His experience in these organizations has allowed him to develop and refine his expertise in the field.
Collaborations
Boyoung Kim has collaborated with notable professionals in his field, including Bob Dale Brown and Henryk T Dudek. These collaborations have likely contributed to the advancement of his research and innovations.
Conclusion
Boyoung Kim is a distinguished inventor whose work in inhibiting LDHA expression showcases his commitment to advancing biotechnology. His contributions are poised to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile